← Back to Search

Meal Replacements for Weight Loss and Diabetes

N/A

Waitlist Available

Led By Dr Dylan MacKay, PhD

Research Sponsored by University of Manitoba

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Female participant who is pregnant, lactating or planning pregnancy during the course of the program

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at enrollment (week 0) and end of study (week 16)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if using WI meal replacements in the Wellness Institute's Weight Loss Clinic program is feasible and helps with weight loss. They will compare the weight loss clinic program with and without the meal

Who is the study for?

This trial is for individuals with obesity, diabetes, or prediabetes who are interested in weight loss and diabetes remission. Participants should be willing to follow the Wellness Institute's Weight Loss Clinic program for 16 weeks and log their meal replacement consumption.

What is being tested?

The study tests if adding plant-based meal replacements (bars or shakes) to a weight loss clinic program can help with weight loss and improve lifestyle behaviors compared to the same program without these products. It also looks at whether it helps in reversing diabetes.

What are the potential side effects?

Since this trial involves food products designed as meal replacements, side effects may include digestive changes depending on individual tolerance to plant-based ingredients.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am not pregnant, breastfeeding, nor planning to become pregnant during the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at enrollment (week 0) and end of study (week 16)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at enrollment (week 0) and end of study (week 16)

This trial's timeline: 3 weeks for screening, Varies for treatment, and at enrollment (week 0) and end of study (week 16) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Feasibility of incorporating the WI meal replacements into their weight loss clinic design.

Secondary study objectives

Cardiovascular Assessment

Changes in BMI

Changes in Body Weight

+4 more

Other study objectives

Change in Physical Activity Behaviour Patterns

Changes in Diastolic Blood Pressure

Changes in Dietary Intake - Available Carbohydrates

+17 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Active Control

Group I: The WLC program plus meal replacementsActive Control1 Intervention

Participants will have a choice on what type of meal replacement they will consume each day (either a bar or a shake) and will record this in the product consumption log.

Group II: The WLC program onlyActive Control1 Intervention

0 / 1Eligibility criteria met